Regina Müller Selected Research

Viral Regulatory and Accessory Proteins

1/2022

Dual signaling via interferon and DNA damage response elicits entrapment by giant PML nuclear bodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Regina Müller Research Topics

Disease

8	Infections 01/2021 - 07/2011
4	Virus Diseases (Viral Diseases) 08/2021 - 06/2015
2	Herpesviridae Infections (Herpesvirus Infection) 01/2022 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 02/2018 - 06/2004
1	Cytomegalovirus Infections (Inclusion Disease) 01/2021
1	Diabetes Mellitus 06/2004
1	Lymphoma (Lymphomas) 11/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 08/2021 - 06/2015
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
2	Protein Kinases (Protein Kinase)IBA 01/2020 - 08/2013
2	EnzymesIBA 01/2020 - 01/2019
2	Insulin (Novolin)FDA Link 02/2018 - 06/2004
2	InterferonsIBA 01/2017 - 01/2016
1	Viral Regulatory and Accessory ProteinsIBA 01/2022
1	Cyclin TIBA 01/2021
1	1,3- bis(bis(pyridin- 2- ylmethyl)amino)propan- 2- olIBA 01/2021
1	LuciferasesIBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	thymidine 5'-triphosphate (thymidine triphosphate)IBA 02/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 06/2015
1	ChromatinIBA 06/2015
1	Antiviral Restriction FactorsIBA 07/2011
1	Messenger RNA (mRNA)IBA 11/2003
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 11/2003
1	Matrix Metalloproteinase 17IBA 11/2003
1	Cathepsin LIBA 11/2003
1	oxidized low density lipoproteinIBA 05/2002
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2002

Therapy/Procedure

2	Therapeutics 02/2018 - 06/2004